Catalyst Wire Dossier Catalyst Wire Dossier

Adjuvanted HPV vaccine

adjuvanted human papillomavirus vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adjuvanted HPV vaccine, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age [Phase 1, Phase 2]

See pricing